Literature DB >> 16466947

Novel and Mediterranean beta thalassemia mutations in the indigenous Northern Ireland population.

M Knott1, K M A Ramadan, G Savage, F G C Jones, M El-Agnaf, M F McMullin, M J Percy.   

Abstract

beta thalassemia is one of the most common genetic diseases worldwide resulting from aberrant beta-globin chain production. It is highly prevalent in regions with endemic malaria, but it is also present at low frequency in the indigenous populations of non-tropical areas such as Britain. Screening beta thalassemia trait individuals from Northern Ireland has detected 2 Mediterranean mutations, 39 (C --> T) and IVS-I-110 (G --> A); the previously reported IVS-II-850 (G --> A) mutation originally described in individuals of Scottish/English ancestry; and 2 novel mutations, initiation codon A --> C and 109 delG. Haplotype analysis indicates that the Mediterranean mutations are present on previously described haplotypes, suggesting that they have arisen due to migration. It remains to be established whether the novel mutations have arisen de novo in Northern Ireland.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16466947     DOI: 10.1016/j.bcmd.2005.12.005

Source DB:  PubMed          Journal:  Blood Cells Mol Dis        ISSN: 1079-9796            Impact factor:   3.039


  3 in total

1.  Molecular basis of transfusion dependent beta-thalassemia major patients in Sabah.

Authors:  Lai Kuan Teh; Elizabeth George; Mei I Lai; Jin Ai Mary Anne Tan; Lily Wong; Patimah Ismail
Journal:  J Hum Genet       Date:  2013-12-26       Impact factor: 3.172

2.  Interaction of Hb South Florida (codon 1; GTG-->ATG) and HbE, with beta-thalassemia (IVS1-1; G-->A): expression of different clinical phenotypes.

Authors:  Jin-Ai Mary Anne Tan; Kim-Lian Tan; Khairul Zaman Omar; Lee-Lee Chan; Yong-Chui Wee; Elizabeth George
Journal:  Eur J Pediatr       Date:  2008-11-26       Impact factor: 3.183

3.  Refinement of evolutionary medicine predictions based on clinical evidence for the manifestations of Mendelian diseases.

Authors:  Daniela Šimčíková; Petr Heneberg
Journal:  Sci Rep       Date:  2019-12-09       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.